| EPITOPE SUMMARY | |
|---|---|
| CLGGLLTMV is a linear peptidic epitope (epitope ID ) studied as part of Latent membrane protein 2 (UniProt:P13285) from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity in publication(s), tested in T cell assays, B cell assays, MHC ligand assays and has 3D structure(s) . | |
| CURATED EXPERIMENTAL DATA | |
|---|---|
MHC Ligand Assay(s) | |
| MHC molecule | Positive / All |
| HLA-A*02:01 | / |
| HLA-A2 | / |
| HLA-A*02:03 | / |
| HLA-A*02:06 | / |
| HLA-A*02:07 | / |
| HLA-A*02:11 | / |
| HLA-A*02:12 | / |
| HLA-A*02:16 | / |
| HLA-A*02:19 | / |
| HLA-A*69:01 | / |
| HLA-A*11:01 | / |
| HLA-A*24:02 | / |
| HLA-B*40:01 | / |
| HLA-B*58:01 | / |
| HLA-C*07:02 | / |
| HLA-C*08:01 | / |
B Cell Assay(s) | |
| Assay Type | Positive / All |
| qualitative binding | / |
| dissociation constant KD | / |
| off rate | / |
| on rate | / |
| antibody-dependent cellular cytotoxicity | / |
| complement-dependent cytotoxicity | / |
| neutralization | / |
T Cell Assay(s) | |
| Assay Type | Positive / All |
| IFNg release | / |
| qualitative binding | / |
| cytotoxicity | / |
| IL-2 release | / |
| TNFa release | / |
| activation | / |
| dissociation constant KD | / |
| granzyme B release | / |
| IL-10 release | / |
| proliferation | / |
| degranulation | / |
| GM-CSF release | / |
| IL-17 release | / |
| IL-1b release | / |
| IL-4 release | / |
| IL-5 release | / |
| IL-6 release | / |
| IL-8 release | / |
| off rate | / |
| on rate | / |
| pathogen burden after challenge | / |
| perforin release | / |
| tumor burden after challenge | / |
| tumor burden after challenge after adoptive transfer | / |
| EXTERNAL RESOURCES | |
|---|---|
| Resource | Link |